PIK3CB/p110β is a selective survival factor for glioblastoma

BACKGROUND: Glioblastoma (GBM) is difficult to treat. Phosphoinositide 3-kinase (PI3K) is an attractive therapeutic target for GBM; however, targeting this pathway to effectively treat GBM is not successful because the roles of PI3K isoforms remain to be defined. The aim of this study is to determin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Pridham, Kevin J, Le, Lamvy, Guo, Sujuan, Varghese, Robin T, Algino, Sarah, Liang, Yanping, Fajardin, Renee, Rodgers, Cara M, Simonds, Gary R, Kelly, Deborah F, Sheng, Zhi
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Basic and Translational Investigations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909664/
https://ncbi.nlm.nih.gov/pubmed/29016844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox181
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki